Views & Analysis Making it as an oncology biotech in the UK We speak to R&D experts to find out how oncology biotechs can get the support they need to be successful in the competitive UK ecosystem
News Vogenx surpasses expectations with $81m IPO With $81.3 million raised, Vogenx is the latest in a staggering summer of biotech IPOs. But the queue past this point looks thin.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.